ABSTRACT BACKGROUND: Identifying beneficial surrogate genetic markers in psychiatric disorders is crucial but challenging. METHODS: Given that scalp hair follicles are easily accessible and, like the brain, are derived from the ectoderm, expressions of messenger RNA (mRNA) and microRNA in the organ were examined between schizophrenia (n for first/second 5 52/42) and control subjects (n 5 62/55) in two sets of cohort. Genes of significance were also analyzed using postmortem brains (n for case/control 5 35/35 in Brodmann area 46, 20/20 in cornu ammonis 1) and induced pluripotent stem cells (n 5 4/4) and pluripotent stem cell-derived neurospheres (n 5 12/12) to see their role in the central nervous system. Expression levels of mRNA for autism (n for case/control 5 18/24) were also examined using scalp hair follicles. RESULTS: Among mRNA examined, FABP4 was downregulated in schizophrenia subjects by two independent sample sets. Receiver operating characteristic curve analysis determined that the sensitivity and specificity were 71.8% and 66.7%, respectively. FABP4 was expressed from the stage of neurosphere. Additionally, microarraybased microRNA analysis showed a trend of increased expression of hsa-miR-4449 (p 5 .0634) in hair follicles from schizophrenia. hsa-miR-4449 expression was increased in Brodmann area 46 from schizophrenia (p 5 .0007). Finally, we tested the expression of nine putative autism candidate genes in hair follicles and found decreased CNTNAP2 expression in the autism cohort. CONCLUSIONS: Scalp hair follicles could be a beneficial genetic biomarker resource for brain diseases, and further studies of FABP4 are merited in schizophrenia pathogenesis.
The disease mechanisms underlying psychiatric illnesses remain largely undetermined. Great efforts have gone into identifying novel biomarkers that would assist in the development of objective diagnostic tools and novel therapeutic and prophylactic interventions, as well as facilitate the subdivision of disease states, based on pathogenesis, for optimal drug selection. There are, however, major obstacles in the search for novel biomarkers, primarily the difficulty in obtaining brain tissue from living donors and the lack of accurate experimental animal models. Brain is an ectodermal tissue and shares its developmental origins with scalp hair follicles, which are readily accessible miniorgans within the skin. Despite their shared embryonic origins, hair follicles have not previously been utilized as a bio-resource in the hunt for proxy genes in psychiatric diseases. In the current study, we first examined whether schizophrenia-relevant genes, namely those related to the γ-aminobutyric acid (GABA)ergic system (1-3), myelin (3) (4) (5) , and fatty acids (6) (7) (8) (9) (10) (11) , are expressed in hair follicles and if expressed whether expression is differential between cases and control subjects, using an exploratory sample set. Next, we attempted to validate any differential expression and examine the effects of potential confounding factors using a second independent sample set. We then analyzed the identified biomarker candidate FABP4/ fatty acid binding protein 4 (FABP4) expression in serum, postmortem brain samples, induced pluripotent stem cells (iPSCs), and iPSC-derived neurospheres. In addition to messenger RNA (mRNA), we also examined the expression levels of microRNA (miRNA) in hair follicles, postmortem brains, iPSCs, and iPSC-derived neurosphere samples from patients with schizophrenia and control subjects. Lastly, we tested candidate gene expression in hair follicles from patients with autism. Based on the results of our comprehensive analysis, we proposed scalp hair follicles as a beneficial genetic resource for schizophrenia and autism in the search for potential biomarkers.
METHODS AND MATERIALS Scalp Hair Follicle Samples
All samples were collected from ethnic Japanese within Japan. The first set of exploratory scalp hair follicle samples for schizophrenia and control subjects was derived from residents in the northern district of Kanto, while the confirmatory second set came from the Tokyo area. Diagnoses were made by at least two experienced psychiatrists, using DSM-IV criteria. Demographic data for scalp hair follicle samples derived from schizophrenia are described in Table 1 . The scalp hair follicle samples from autism participants and control subjects were collected from the Chubu area. The diagnosis of autism spectrum disorder was made using the DSM-IV-TR criteria. We then administered the Autism Diagnostic InterviewRevised (ADI-R) (12) to 14 of 18 cases and made a confirmed diagnosis of autism for those 14 cases. Interviews for the ADI-R were conducted by experienced child psychiatrists who are licensed to use the Japanese version of the ADI-R (13) . Demographic data relating to scalp hair follicle samples for autism are described in Table 1 .
RNA Extraction and Quantification
Ten hairs were plucked from the scalp of each subject using forceps. The hairs were checked for the presence of a sheath. Hairs were trimmed to approximately 1.5 cm in length, containing the bulb region, and dropped into a 1.5 mL microfuge tube (BM Equipment, Tokyo, Japan) containing RNAlater solution (Ambion, Grand Island, New York). Total RNA was extracted using the RNAqueous-Micro kit (Ambion). Singlestranded complementary DNA (cDNA) was synthesized using SuperScript VILO Master Mix (Invitrogen, Grand Island, New York). Quantitative reverse-transcription PCR (qRT-PCR) analysis of mRNAs was conducted using an ABI7900HT Fast RealTime PCR System (Applied Biosystems, Grand Island, New York). TaqMan probes were TaqMan Gene Expression Assays products (Applied Biosystems). All qRT-PCR data were captured using the SDS v2.4 (Applied Biosystems). The ratios of relative concentrations of target molecules to the GAPDH gene (target molecule/GAPDH gene) were calculated. All reactions were performed in triplicate based on the standard curve method.
Statistical Analysis
We used the interquartile range to find outliers. The differences between the 25th (quartile 1) and 75th percentiles (quartile 3) were used to identify extreme values (outliers) in the tails of the distribution. Statistical evaluation was performed by MannWhitney U test for means between patient and control groups and by Spearman's R test for correlation using SPSS software version 19 (IBM, Tokyo, Japan).
Analyses of miRNA Expressions and Potential Targets of miRNAs
For microarray-based miRNA analysis, we used the miRBase Rel. 18.0 platform (Agilent Technologies, Santa Clara California), capable of measuring 1919 human mature miRNAs in the age-/sex-matched subset of the first hair follicle sample set (Table S1 in Supplement 1). The miRNAs were labeled using the miRNA Complete Labeling Reagent and Hyb Kit (Agilent Technologies) and hybridized to the arrays. Images were scanned with a High-Resolution C scanner (Agilent Technologies) and analyzed using GeneSpring GX (Agilent Technologies). Comparisons of miRNA expression values between schizophrenia and control groups were performed using GeneSpring 12.6 (Agilent Technologies). To normalize the intermicroarray range of expression intensities, the percentile shift method (90th percentile) was used. The genes whose expression data were available in more than 50% of hybridizations were statistically evaluated between schizophrenia and control groups using the two-tailed Mann-Whitney U test. For quantification of individual miRNAs, we performed TaqMan-based miRNA qRT-PCR (Applied Biosystems, Grand Island, New York) according to the manufacturer's instructions, using U6 snRNA as a control probe. All reactions for miRNA quantification were also performed in triplicate, based on the standard curve method. Statistical evaluation methods were the same as those for mRNA. 
Immunohistochemistry
The plucked hairs were rinsed briefly in phosphate-buffered saline and dropped into a 1.5 mL microfuge tube containing 1 mL of 10% neutral-buffered formalin (41C, 1 hour). The fixed hairs were pre-embedded in 4% agarose (Sigma-Aldrich, St Louis, Missouri) in phosphate-buffered saline, pH 7.4. At this point, it was possible to orientate the hairs into their desired position for either longitudinal or transverse sectioning. Blocks were embedded in capsules, which were filled with O.C.T. compound (Sakura Finetek, Tokyo, Japan). Cryostat sections (8 μm thick) of plucked hair follicles were processed for immunohistochemistry. The sections were blocked with 10% goat serum in .05 mol/L Tris buffered saline plus .05% Tween 20 (TBST), followed by three rinses in TBST (20 min each). The primary antibodies were applied for overnight at 41C. After three washes in TBST (20 min each), secondary antibodies were applied to sections at room temperature (1 hour). Slides were counterstained with 4',6-diamidino-2-phenylindole to highlight nuclei. After washing in TBST, the slides were mounted in PermaFluor Aqueous Mounting Medium (Thermo Fisher Scientific, Waltham, Massachusetts). Fluorescent signals were detected using a confocal laser-scanning microscope FV1000 (Olympus, Tokyo, Japan).
Antibodies
See Supplementary Methods and Materials in Supplement 1.
Analysis of FABP4 Protein Levels in Serum
Postmortem Brain Analysis
Establishment of iPSC Lines
Dermal fibroblasts (human dermal fibroblasts) from the facial dermis of a 36-year-old Caucasian female subject (Cell Applications, Inc., San Diego, California) were used to establish control iPSCs 201B7 and YA9 (14) . The remaining control iPSCs, WD39 and KA23, were generated from a 16-year-old Japanese female subject (15) and a 40-year-old Japanese male subject (Matsumoto, Ph.D., et al., personal communication, 2013), respectively. The 201B7 iPSCs were kindly provided by Yamanaka, M.D., Ph.D., Kyoto University (14) . The iPSCs YA9, WD39, and KA23 have been described in a previous report (15) . The schizophrenia derived iPSCs from patients with 22q11.2 deletions SA001 and KO001 were generated from Japanese female subjects aged 37 and 30 years old, respectively (see Clinical History in Supplement 1).
The maintenance of human dermal fibroblasts, lentiviral production, retroviral production, infection, stem cell culture, and characterization were performed as described previously (15) .
In Vitro Neural Differentiation of Induced Pluripotent Stem Cells
The iPSCs were plated in T75 flasks after dissociation into single cells and cultured for 14 days in neural culture medium supplemented with leukemia inhibitory factor (Merck Millipore, Darmstadt, Germany) and basic fibroblast growth factor (Peprotech, Rocky Hill, New Jersey). Neurospheres were passaged repeatedly by culturing in the same manner (16, 17) .
Comparative Genomic Hybridization Array Analysis
Ethical Issues
This study was approved by the Ethics Committees of RIKEN and all participating institutes, including the Keio University School of Medicine, an ethical committee for skin biopsy and iPSC production (approval No. 20080016), and conducted according to the principles expressed in the Declaration of Helsinki. All control subjects and patients gave informed, written consent to participate in the study after being provided with and receiving an explanation of study protocols and objectives.
RESULTS

Expression of mRNA in Scalp Hair Follicles from Schizophrenia and Control Subjects
Gene expression profiles of schizophrenia postmortem brains have been well studied. However, studies have been hampered by uncontrollable confounding factors associated with postmortem brains and an inaccessibility of brain tissue from living donors. Therefore, we set out to analyze gene expression in hair follicles. Previous studies provide substantial support for reduced expression of genes related to oligodendrocyte and GABAergic systems in schizophrenia pathology (1) (2) (3) (4) . In addition, our (6, 7, 9) and other studies (8, 10, 11) on FABPs (genes for fatty acid binding proteins) raise the possibility of disturbed lipid metabolism in the susceptibility to this disease. Based on these findings, we selected 22 genes: 8 from the GABAergic system, 9 with myelin relevance, and 5 with lipid relevance ( Table 2 ). The amount of mRNA from an individual subject's hair follicles was not enough for a systemic cDNA microarray. We used GAPDH as an internal control. An exploratory scalp hair follicle sample panel (the first sample set) consisted of samples from 52 patients with schizophrenia and 62 control subjects (Table 1) . qRT-PCR analysis showed that seven genes, namely CALB2, SST, CNP, PMP22, FABP4, FABP7, and FAAH were differentially expressed (p , .05) in samples from schizophrenia compared with control subjects (Table 2 ; Figure S1 in Supplement 1).
To replicate the finding, we examined the expression levels of these seven genes using an age-/sex-matched, independent confirmatory set (a second sample set) composed of 42 patients with schizophrenia and 55 control subjects (Table 1) . Of the seven genes, only FABP4 showed significantly decreased expression (an average reduction of 43% compared with a reduction of 40% in the first set of samples) in schizophrenia samples ( Figure 1A ; Table 2 ). Correlation analyses demonstrated no significant effects for age, dose of Scalp Hair Follicles as Disease Biomarkers antipsychotics [haloperidol equivalent (18, 19) ], or duration of illness on the expression levels of FABP4 ( Figure S2A -C in Supplement 1). Since serum levels of Fabp4 were reported to be affected by nutritional fluctuations in mice (that is, suppressed by feeding) (20) , we examined the effect of sampling time after the last meal on FABP4 expression in hair follicles and found no significant change ( Figure S2D in Supplement 1). Nor did we detect an effect for sex on FABP4 levels: male control versus female control subjects, p 5 .950; male schizophrenia versus female schizophrenia subjects, p 5 .360; male (control 1 schizophrenia subjects) versus female (control 1 schizophrenia subjects), p 5 .387; all evaluated by the MannWhitney U test.
Circulating FABP4 is known to be associated with metabolic markers (21, 22) , so we examined the effects of weight, height, body mass index, and body fat percentage on FABP4 expression in the second hair follicle sample set ( Figure S3 in Supplement 1). None of these factors affected the expression ratios of FABP4/GAPDH in hair follicles. Despite the fact that olanzapine alters lipid metabolism (23, 24) , we detected no significant correlation between FABP4 expression levels in hair follicles and olanzapine dose (mg/day) in the second set of schizophrenia samples (Spearman's rho = 2.2289; 95% confidence interval = 2.5258 to .1178; p = .180).
From these results, FABP4 expression levels in hair follicles would appear to be a robust marker for schizophrenia. Receiver operating characteristic curve analysis determined an optimal cutoff level of .769, based on the minimum distance from the curve to upper left corner (= .191) and area under the curve = .713 (95% confidence interval = .609-.817) ( Figure S4 in Supplement 1). With this cutoff level for the FABP4/GAPDH mRNA ratio, the sensitivity, specificity, and positive and negative predictive values were 71.8%, 66.7%, 60.9%, and 76.6%, respectively. Figure 2A shows the structure of a hair follicle (25, 26) . Moving inward, a plucked scalp hair consists of the following components: the outer root sheath, companion layer, inner root sheath (IRS), the cortex, and medullar. Each of these components has an epidermal origin and each compartment expresses specific genes from the keratin family (26) ( Figure 2B ). FABP4 is coexpressed with K71 in the IRS cuticle layer and displays partially overlapping expression with K85 in the cuticle, matrix/precortex, and mid/upper cortex (27) . However, FABP4 shows scant co-expression with K14 in the outer root sheath layer ( Figure 2C, D) . These results indicate that FABP4 is expressed in the IRS and part of the hair cortex.
Immunohistochemical Analysis of FABP4 in Scalp Hair Follicles
Expression of FABP4 in Serum and Postmortem Brains
We measured FABP4 protein levels in the same cohort as the second hair follicle sample, using an enzyme-linked immunosorbent assay kit, to see whether serum levels of FABP4 could Scalp Hair Follicles as Disease Biomarkers also be a proxy for schizophrenia. However, the measure did not differ significantly between schizophrenia and control samples, although a trend of increase was seen in schizophrenia ( Figure 1B ). In addition, using the second sample cohort, there was no significant correlation between serum FABP4 and FABP4 mRNA levels in hair follicles ( Figure 1C ). Interestingly, in contrast to findings in mice (20) , serum FABP4 levels were not affected by time elapsed after the last meal in either disease or control groups ( Figure S5 in Supplement 1). In postmortem brains, FABP4 transcript expression was significantly elevated in the frontal cortex (Brodmann area [BA]46) of schizophrenia compared with control samples (p 5 .0047) ( Figure 1D ), suggesting its role in schizophrenia pathophysiology. Expression of FABP4 in hippocampus cornu ammonis 1 remained unchanged between schizophrenia and control samples ( Figure 1E ), implicating region specificity for the function of FABP4 in schizophrenia. Both of these brain regions showed particularly high expression levels in four schizophrenia samples derived from patients not recorded to have taken particular therapeutic drugs (Table S3 in Supplement 1), although the possibility of drug effects cannot be excluded.
Expression Analysis of miRNAs in Scalp Hair Follicles and Postmortem Brains
We further performed microarray-based miRNA analysis and measured the expression levels of 1919 human mature miRNAs using the miRBase Release 18.0 platform (Agilent) in an age-and sex-matched subset of the first hair follicle sample set (Table S1 in Supplement 1). We detected three miRNAs, which satisfied our criteria of an absolute fold change (FC) (schizophrenia group/control group) $ 2 and p , .05 (by Mann-Whitney U test, two-tailed). These were hsa-miR-4449 (FC 5 3.45, p 5 .0032), hsa-miR-1237 (FC 5 2.55, p 5 .028), and hsa-miR-4769-3p (FC 5 2.03, p 5 .028). In the next step, we tested these three miRNAs in the second hair follicle sample set (Table 1) , using qRT-PCR, with U6 small nuclear RNA as a control probe. hsa-miR-4449 showed a top hit with upregulation, although not to significant levels, in schizophrenia (FC 5 1.25, p 5 .063) ( Figure 3A) .
In postmortem brains (BA46), hsa-miR-4449 showed increased expression (p 5 .0007) in schizophrenia samples ( Figure 3B ), suggesting possible contribution of this gene also to schizophrenia.
Expression Analysis of FABP4 and hsa-miR-4449 in iPSCs and iPSC-Derived Neurospheres
Recently, iPSCs have been used for human disease modeling, particularly in neurological disorders (28) (29) (30) . We have established iPSCs from control subjects (one line each from four subjects) and schizophrenia patients carrying a 22q11.2 microdeletion (two lines each from two patients) (31) (Figure 4) . Then, we established three neurosphere lines from each iPSC line. We chose 22q11.2 deletion carriers for analysis (for comparative genomic hybridization array analysis using the iPSCs, see Supplementary Methods and Materials in Supplement 1), since the 22q11.2 deletion is a well-defined (B) Schematic presentation of epithelial/hair keratin expression patterns. Keratin K71 is expressed in the three inner root sheath (IRS) layers, while K14 is known as outer root sheath (ORS) keratin. Keratin K85 is present in the hair-forming compartment. (C) Immunofluorescent labeling of FABP4 and hair keratins (K14, K71, and K85) in scalp hair follicles. K14 is uniformly expressed throughout the widely stratified follicular ORS. K71 is expressed in all compartments of the hair IRS. Keratin K85 expression extends from the hair matrix to the upper cortex and the hair cuticle. FABP4 is seen in the IRS and part of the hair cortex (merged green and red). 4',6-diamidino-2-phenylindole (DAPI) was used for nuclear staining. (D) Magnified picture of (C). APM, arrector pili muscle; cl, companion layer; DP, dermal papilla; DS, dermal sheath; gm, germinative matrix; ma/co, matrix/precortex; med, medulla; SG, sebaceous gland.
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Biological Psychiatry July 15, 2015; 78:116-125 www.sobp.org/journalgenetic feature with the highest risk for schizophrenia, affecting around .3% of schizophrenia patients (32) . The FABP4 gene shows little expression in iPSCs derived from either control subjects or patients (data not shown). The gene is expressed in neurospheres, suggesting that its expression starts at a very early stage of neuronal development. Neurospheres are composed of free-floating clusters of neural stem or progenitor cells, differentiated from iPSCs. However, FABP4 expression levels were not significantly different between control subjects and cases ( Figure S6 in Supplement 1; expressional variance in the control group was large). Expression of hsa-miR-4449 showed a trend of upregulation in iPSCs from patients (p 5 .0571) ( Figure 3C) ; however, there was no differential expression between neurospheres derived from control subjects and cases ( Figure 3D ).
Examination of Autism Samples
We also performed a preliminary study to examine whether expression patterns of putative autism genes in scalp hair follicles could discriminate between autism and control samples. The sample cohort is shown in Table 1 . We selected genes from candidates for autism susceptibility and included FABP4, due to the genetic overlap between schizophrenia and autism (33) . The remaining genes were FABP7 (9), NHE6 (34),
, and SLC25A12 (35) . Of the nine genes, only CADPS2 (p 5 .0401) and CNTNAP2 (p 5 .0212) showed significantly decreased expression in autism-derived samples compared with control follicles ( Figure S7 in Supplement 1). It should be noted that the average age of autism subjects was significantly lower than that of control subjects (Table 1) and that CADPS2 levels showed a positive correlation with age in autism and control 1 autism groups ( Figure S8 in Supplement 1).
Therefore, we can only safely nominate CNTNAP2 level as a potentially valid marker for autism in this study ( Figure S9 in Supplement 1). Approximately half of the examined patients were medicated. However, these patients were not outliers in terms of CNTNAP2 expression in hair follicles; that is, they fell within the mean 6 2SD (detailed data not shown).
DISCUSSION
We examined and attempted to validate expression levels of schizophrenia and autism candidate genes using scalp hair follicles as a surrogate source of disease markers. Of the protein-coding genes tested that are putative schizophrenia genes, FABP4 was confirmed to be downregulated in disease samples in our two-stage analyses. Our low rate of replication could be due to two main factors. First, the current sample size is insufficient, which may represent one of the limitations in this study. Another potential reason might be that stable detection of expression levels is dependent on where a particular gene is expressed in the hair follicle. For instance, FABP4 is expressed in more central portions (IRS and cortex) of the hair follicle and the integrity of these areas may be well maintained during the plucking process, leading to more consistent results. FABP4, also known as adipocyte-specific fatty acid-binding protein, belongs to the fatty acid-binding protein super family, whose members have molecular masses of approximately 15,000. FABPs are highly conserved cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. It is thought that FABPs are active in fatty acid uptake, transport, and metabolism. In the periphery, FABP4 is highly expressed in adipose tissue and moderately expressed in macrophages, endothelial cells, and bone marrow (37) . The protein has been intensively studied in terms of systemic insulin sensitivity and Neurosphere p = 0.0007
Scalp Hair Follicles as Disease Biomarkers lipid and glucose metabolism, both of which correlate with inflammatory mechanisms (21) . Since the results showing downregulation of FABP4 in scalp hair follicles from schizophrenia subjects are robust against confounding factors, including those related to metabolic state, our findings are unlikely to represent either metabolic or inflammatory conditions. In addition, our patients had been treated with secondgeneration antipsychotics, including olanzapine, which often induce metabolic syndrome, but FABP4 levels in hair follicles were independent of drug dose and duration of illness. Conformingly, there was no significant correlation between serum FABP4 and FABP4 transcript levels in hair follicles. Therefore, elevated FABP4 expression in hair follicles may point toward a pathophysiological step in schizophrenia.
In our protocol, all cells in neurospheres expressed the neural markers Nestin, or β3-tubulin, suggesting that our neurospheres consist almost entirely of neural stem or progenitor cells (38) . The fact that FABP4 is expressed in neurospheres may suggest a potential role in neuronal stem cell maintenance or neuronal differentiation or both processes. Although iPSC-derived neurospheres showed no significant differences in FABP4 expression levels between control and schizophrenia cohorts, before a conclusion can be made, it would be necessary to examine a much larger cohort. According to the Human Protein Atlas database (Knut and Alice Wallenberg Foundation, Stockholm, Sweden; http://www.proteinatlas.org/), FABP4 transcripts are expressed in neuronal cells (35%) and glial and endothelial cells (65%) of the adult cerebral cortex.
To evaluate whether common genetic variants of FABP4 determine a predisposition to schizophrenia, we performed a genetic association study using approximately 2000 schizophrenia cases and 2000 age-and sex-matched control subjects with six tag single nucleotide polymorphisms (Supplementary Methods and Materials in Supplement 1). This analysis found no significant allelic or genotypic association (Table S4 in Supplement 1). The FABP4 gene is composed of two haplotype blocks, based on Gabriel's confidence intervals (39) (Figure S10 in Supplement 1). Haplotype analysis also failed to reveal any significant signals. The exact reasons for the different directional changes seen in hair follicles, serum, postmortem brains, and neurospheres between control and schizophrenia subjects remain unknown. All FABP family genes contain a canonical TATA box, followed by a conserved gene structure. The tissue-specific and developmental regulation of FABP subtype expression, including that of FABP4, is thought to be controlled by unidentified genomic regulatory elements (6, 40) .
Mechanistically speaking, although not yet confirmed, the FABP4 may be more central to schizophrenia pathophysiology beyond being a mere biomarker for disease. This is based on the following observations: 1) FABP4 is expressed in the early neuronal lineage (a current finding); 2) other FABP genes are reported to be associated with schizophrenia (6,7,9,11); and 3) there is evidence linking polyunsaturated fatty acids (endogenous ligands for FABPs) with schizophrenia etiology (41) and brain development (42) .
Regarding miRNA, we detected hsa-miR-4449 from a total of 1919 human mature miRNAs in this study. Although its expression in hair follicles was not significantly altered, expression did show significant upregulation in postmortem brains (BA46) and a trend of increase in iPSCs from schizophrenia samples. Webbased target predictions for hsa-miR-4449 hit 18 protein-coding genes using TargetScan (Whitehead Institute for Biomedical Research, Release 6.2) ( Table S5 in Supplement 1) and 10 protein-coding genes using miRDB (Washington University School of Medicine; http://mirdb.org/miRDB/) ( Table S6 in Supplement 1). Between the two programs, the following three genes overlapped: 1) HIC1; 2) RBM4; and 3) TOMM40. Although the predicted roles for these three genes in schizophrenia pathogenesis are not known, hsa-miR-4449 would make an interesting candidate in future studies, since this miRNA is expressed in early human neurodevelopmental stages such as iPSCs and iPSC-derived neurospheres.
In the analysis of autism-derived scalp hair follicles, we found significant downregulation of CNTNAP2 in sufferers compared with control subjects and that the results are not affected by age. CNTNAP2, which encodes the contactin associated protein-like 2, is one of the strongest autism susceptibility genes with convergent evidence from several independent studies (43) .
In the case of schizophrenia, biomarkers are an essential tool, particularly in the early phase of disease onset, such as the prodromal phase or at-risk mental state (44) . It would be important to confirm whether FABP4 expression levels in scalp hair follicles constitute a valid measure for discriminating between those individuals in at-risk mental state who will spontaneously recover and those who will need therapeutic treatment. As a starting point, it is interesting that the decreased FABP4 levels in schizophrenia-derived hair follicles are not influenced by duration of illness.
In summary, our results provide an original concept for identifying novel disease markers, with potential benefits for the clinical practice of psychiatric medicine, as well as possible applications to other brain disorders. The development of methods that enable the analysis of a transcriptome using hair follicles (10 samples) would be highly desirable. At the moment, approximately 40 ng of total RNA is extractable from a single hair follicle, but this amount is not enough for currently available cDNA microarray analysis, a technique which needs roughly 1 mg of total RNA.
